Stock USNU U.S. NEUROSURGICAL HOLDINGS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News U.S. NeuroSurgical Holdings, Inc.

Equities

USNU

US90336K1016

Market Closed - OTC Markets
Other stock markets
 11:26:19 2024-04-29 am EDT 		5-day change 1st Jan Change
0.72 USD +1.41% Intraday chart for U.S. NeuroSurgical Holdings, Inc. -4.00% +60.00%
Apr. 05 U.S. NeuroSurgical Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Jan. 10 U.S. NeuroSurgical Holdings, Inc. announced that it expects to receive $2 million in funding CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
U.S. NeuroSurgical Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
U.S. NeuroSurgical Holdings, Inc. announced that it expects to receive $2 million in funding
CI
U.S. NeuroSurgical Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
U.S. NeuroSurgical Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
U.S. NeuroSurgical Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
U.S. NEUROSURGICAL HOLDINGS, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
U.S. NeuroSurgical Holdings, Inc. Appoints William St. Lawrence as a Non-Executive Director
CI
U.S. NEUROSURGICAL HOLDINGS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)
AQ
U.S. NeuroSurgical Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
U.S. NEUROSURGICAL HOLDINGS, INC. Management Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
U.S. NeuroSurgical Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
U.S. NEUROSURGICAL HOLDINGS, INC. : Changes in Registrant's Certifying Accountant (form 8-K)
AQ
U.S. NEUROSURGICAL HOLDINGS, INC. Management Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
U.S. NeuroSurgical Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
U.S. NEUROSURGICAL HOLDINGS, INC. Management Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q/A)
AQ
U.S. NEUROSURGICAL HOLDINGS, INC. : Non-Reliance on Previous Financials, Audits or Interim Review (form 8-K)
AQ
U.S. NEUROSURGICAL HOLDINGS, INC. Management Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
U.S. NEUROSURGICAL HOLDINGS, INC. - 10-K/A - Management's Discussion and Analysis of Financial Condition and Results of Operations.
AQ
U.S. NeuroSurgical Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
U.S. NEUROSURGICAL HOLDINGS, INC. : Non-Reliance on Previous Financials, Audits or Interim Review (form 8-K)
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. USNU Stock
  4. News U.S. NeuroSurgical Holdings, Inc.